Cultured allogeneic fibroblast injection vs. fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment
Author:
Affiliation:
1. Skin Research Center; Shahid Beheshti University of Medical Sciences; Tehran Iran
2. School of Advanced Technologies in Medicine; Shahid Beheshti University of Medical Sciences; Tehran Iran
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16338/fullpdf
Reference21 articles.
1. Progress in epidermolysis bullosa research: summary of DEBRA International Research Conference 2012;Bruckner-Tuderman;J Invest Dermatol,2013
2. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes;Varki;J Med Genet,2007
3. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing;Woodley;Mol Ther,2007
4. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue;Ortiz-Urda;J Clin Invest,2003
5. Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds;Lo;J Am Acad Dermatol,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy;Stem Cell Reviews and Reports;2024-03-02
2. Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis;Healthcare;2024-01-19
3. Nanostructured fibrin-agarose hydrogels loaded with allogeneic fibroblasts as bio-dressings for acute treatment of massive burns;Biomedicine & Pharmacotherapy;2023-12
4. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects;Therapeutics and Clinical Risk Management;2023-06
5. Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds;Molecular Diagnosis & Therapy;2022-10-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3